b12 labs
AI-powered chemical synthesis platform for pharmaceutical and biotech research, specializing in complex molecules, multi-step targets, and novel scaffolds.
About b12 labs
b12 makes high-value molecules that are otherwise hard to make. We help pharma companies plan and make new drugs, accelerating early-stage drug discovery from years to months.
Andres built the first AI agent that can autonomously think and make molecules in a robotic lab, published in Nature Machine Intelligence (1000+ citations), and won the best paper award at the NeurIPS AI for Science conference. Zlatko is a 3x National Chemistry Olympiad champion, competed at IChO level, and medicinal chemist who has worked at Roche and leading lab robotics companies.
Combined, we have an extensive network of hundreds of chemists, automation scientists, and AI 4 Science researchers.
We run paid pilots with big pharma companies, demonstrating that our platform planned a set of experiments that achieved full conversion in a single attempt, eliminating the iteration cycle.
Products
HTE-ready plate designer that turns proposed chemical transformations into grounded experimental plans, optimizing catalysts, ligands, bases, and solvents.
Lab automation tool that translates optimized conditions into execution-ready protocols for platforms like Chemspeed and Opentrons without coding.
Synthesis service where b12 executes plate screenings and gram-scale synthesis based on user-submitted conditions or catalog selections.
Agentic synthesis system for retrosynthesis that converts molecular ideas into practical, ranked synthesis strategies with model confidence.
Security and compliance
No security details published yet
b12 labs hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim b12 labs